What is VTRS stock price today?

Visit our real-time dashboard for the current VTRS stock price and live market data.

Is VTRS stock going up or down today?

VTRS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy VTRS stock now?

The decision to buy VTRS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is VTRS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for VTRS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is VTRS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if VTRS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is VTRS's P/E ratio?

P/E ratio data for VTRS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is VTRS's market cap?

VTRS (Viatris Inc) has a market capitalization of $10.83 billion, making it a mid-cap stock.

What is VTRS's price to book ratio?

Price-to-book ratio for VTRS is available on our dashboard along with other valuation metrics.

Does VTRS pay dividends?

Yes, VTRS pays dividends with a current yield of 5.38%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is VTRS's dividend yield?

VTRS's dividend yield is 5.38%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is VTRS stock a good long-term investment?

VTRS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is VTRS's revenue growth rate?

Revenue growth data for VTRS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for VTRS are available on our dashboard with complete income statement analysis.

What are the risks of investing in VTRS?

Key risks for VTRS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does VTRS compare to its competitors?

Compare VTRS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize VTRS's performance and positioning.

What is VTRS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for VTRS with bull, base, and bear case scenarios.

What do analysts say about VTRS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for VTRS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is VTRS's next earnings report?

VTRS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

VTRS - Viatris Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Viatris Inc

Viatris Inc (VTRS) common stock

Price Chart

Loading chart...

VTRS Key Statistics

Market Cap

$10.83B

Dividend Yield

5.38%

How VTRS Compares to Peers

VTRS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
VTRS(This stock)	$10.83B	N/A	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 13, 2026 at 7:29 PM EDT

Ready to invest in VTRS?

Commission-free trading available. Affiliate links.

VTRS Lician Score

10% confidence

5.0/10

Neutral

VTRS has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates VTRSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

VTRS Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for VTRS

Dashboard

Enter a ticker to analyze